These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


123 related items for PubMed ID: 2211438

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. A ten-laboratory study of lomefloxacin (NY-198 or SC 47111) antimicrobial activity in Argentina.
    Bianchini HN, Sarachian B, Fernandez A, Paolasso R, Kaufman C, Notario R, Porven G, Ingaramo RA, Perez S, Ferrero SM.
    Diagn Microbiol Infect Dis; 1989; 12(3 Suppl):45S-50S. PubMed ID: 2676328
    [Abstract] [Full Text] [Related]

  • 3. Lomefloxacin sensitivities.
    Smith JM, Hashmi ZS.
    N Z Med J; 1989 Jul 26; 102(872):391. PubMed ID: 2797570
    [No Abstract] [Full Text] [Related]

  • 4. Lomefloxacin (SC-47111 or NY-198). Comparative antimicrobial activity against 2002 clinical isolates from hospitals in Mexico City.
    Durazo F, Resano F, Gonzalez MA.
    Diagn Microbiol Infect Dis; 1990 Jul 26; 13(1):71-5. PubMed ID: 2331854
    [Abstract] [Full Text] [Related]

  • 5. Lomefloxacin sensitivities.
    Smith JM, Hashmi ZS.
    N Z Med J; 1990 Jun 13; 103(891):277-8. PubMed ID: 2356052
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Antimicrobial effects of lomefloxacin in vitro.
    Chambers ST, Peddie BA, Robson RA, Begg EJ, Boswell DR.
    J Antimicrob Chemother; 1991 Apr 13; 27(4):481-9. PubMed ID: 1856127
    [Abstract] [Full Text] [Related]

  • 8. [Bactericidal action of lomefloxacin a new pyridonecarboxylic acid derivative].
    Koikeda S, Okabe H, Shibata H, Hase T, Nakanishi N, Okezaki E, Kato H, Masamune Y.
    Jpn J Antibiot; 1989 Jan 13; 42(1):193-9. PubMed ID: 2468799
    [Abstract] [Full Text] [Related]

  • 9. In vitro activity of lomefloxacin, a difluorinated quinolone, compared with other antimicrobials.
    Qadri SM, Lee GC, Ellis ME.
    Chemotherapy; 1991 Jan 13; 37(3):166-74. PubMed ID: 1889304
    [Abstract] [Full Text] [Related]

  • 10. In vitro activity of MF 5137, a new potent 6-aminoquinolone.
    Wise R, Pagella PG, Cecchetti V, Fravolini A, Tabarrini O.
    Drugs; 1995 Jan 13; 49 Suppl 2():272-3. PubMed ID: 8549329
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. In vitro evaluation of lomefloxacin (NY-198 or SC-47111), a new difluoro-quinolone.
    Jones RN.
    J Chemother; 1989 Jul 13; 1(4 Suppl):165-7. PubMed ID: 16312353
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Comparative in vitro activity of BAY Y 3118 with other fluoroquinolones.
    Molinari G, Schito GC.
    Drugs; 1995 Jul 13; 49 Suppl 2():222-5. PubMed ID: 8549310
    [No Abstract] [Full Text] [Related]

  • 17. Susceptibility pattern of bacterial isolates to lomefloxacin.
    Lalitha MK, Nisha AK, Bhattacharya SS, Ramamoorthy U, Lal HM.
    Indian J Med Res; 1990 May 13; 91():182-4. PubMed ID: 2397938
    [Abstract] [Full Text] [Related]

  • 18. [Tosufloxacin tosilate].
    Shimada K.
    Jpn J Antibiot; 1990 Apr 13; 43(4):583-602. PubMed ID: 2199687
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 7.